A nucleic acid ligand "biochip" is disclosed, consisting of a solid support to which one or more specific nucleic acid ligands is attached in a spatially defined manner. Each nucleic acid ligand binds specifically and avidly to a particular target molecule contained within a test mixture, such as a bodily fluid. The target molecules include, but are not limited to, proteins (cellular, viral, bacterial, etc.) hormones, sugars, metabolic byproducts, cofactor, and intermediates, drugs, and toxins. Contacting the test mixture with the biochip leads to the binding of a target molecule to its cognate nucleic acid ligand. The biochip may then be contacted with a reagent(s) that reacts covalently with proteins and not with nucleic acids. Each protein target in the test mixture may then detected by detecting the presence of the reagent at the appropriate address on the biochip.

 
Web www.patentalert.com

< Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain

< Human E3.alpha. ubiquitin ligase family

> Metallic nanowire arrays and methods for making and using same

> Multispectral plasmonic crystal sensors

~ 00603